Form 8-K - Current report:
SEC Accession No. 0001493152-26-025340
Filing Date
2026-05-27
Accepted
2026-05-27 09:00:14
Documents
11
Period of Report
2026-05-21
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 58550
  Complete submission text file 0001493152-26-025340.txt   227165

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE shph-20260521.xsd EX-101.SCH 3029
3 XBRL LABEL FILE shph-20260521_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE shph-20260521_pre.xml EX-101.PRE 22368
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3345
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41488 | Film No.: 261022351
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)